Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07084441 · ClinicalTrials.gov registry record · Phase 4

Comparison of Outcomes of Management of Bowel Obstruction

A Phase 4 study of Adhesive Small Bowel Obstruction, sponsored by University of Washington.

Recruiting
Registry status
Phase 4
Development phase
550
Enrollment target
3
Study locations

NCT07084441 is a Phase 4 study of Adhesive Small Bowel Obstruction that is actively recruiting participants, run by University of Washington. The registered enrollment target is 550 participants. The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07084441, a Phase 4 study of Adhesive Small Bowel Obstruction, is actively recruiting participants, sponsored by University of Washington.

RECRUITING
Registry status
Phase 4
Development phase
550 participants
Enrollment target
3
Study locations

Study Summary

The Comparison of Outcomes of Management of Bowel Obstruction (COMBO) trial is a patient-level randomized trial of a short course of dexamethasone + supportive care vs supportive care alone for patients with adhesion-related small bowel obstruction (aSBO). The goal of the COMBO trial is to answer the question: Can Dexamethasone increases the proportion of patients with resolution of aSBO with non-operative management (without complication) based on an established minimal important clinical difference.

Interventions

  • OTHER Supportive Care
  • DRUG Dexamethasone

Study Locations (3)

Washington

  • Harborview Medical Center - Seattle
  • UW Medical Center - Northwest - Seattle
  • University of Washington Medical Center Montlake - Seattle

Trial Details

FieldValue
Enrollment Target 550 participants
Start Date 2026-02
Est. Completion 2030-12
Phase Phase 4

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT07084441

The ClinicalTrials.gov registry entry for NCT07084441 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 550 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Adhesive Small Bowel Obstruction appearing as the primary indexed condition, and to 2 interventions - of which Supportive Care is the first listed.

NCT07084441 reports 3 study locations spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT07084441 about?

NCT07084441 is a clinical study titled "Comparison of Outcomes of Management of Bowel Obstruction". The Comparison of Outcomes of Management of Bowel Obstruction (COMBO) trial is a patient-level randomized trial of a short course of dexamethasone + supportive care vs supportive care alone for patients with adhesion-related small bowel obstruction (aSBO). The goal of the COMBO trial is to answer th...

What is the current status of trial NCT07084441?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 550 participants. The study started on 2026-02. Estimated completion is 2030-12.

What conditions does trial NCT07084441 study?

This clinical trial studies the following conditions: Adhesive Small Bowel Obstruction.

What interventions are being tested in trial NCT07084441?

The interventions under investigation include: Supportive Care (OTHER), Dexamethasone (DRUG).

Who is sponsoring clinical trial NCT07084441?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07084441 being conducted?

This trial has 3 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Adhesive Small Bowel Obstruction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.